nach oben

Current Pain and Headache Reports

Erschienen in:

14.03.2022 | Regenerative Pain Medicine/Interventional Pain Medicine (E Cornett Bradley, Section Editor)

Occipital Nerve Stimulation: An Alternative Treatment of Chronic Migraine

verfasst von: Benjamin S. Maxey, John W. Pruitt, Ashley Deville, Carver Montgomery, Alan D. Kaye, Ivan Urits

Erschienen in: Current Pain and Headache Reports | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This paper will examine the efficacy and safety of occipital nerve stimulation as a non-pharmacological alternative treatment for migraine.

Recent Findings

Migraine is characterized as a primary headache disorder with possible premonitory and aura phases, both of which vary greatly in symptomatology. The most common treatments for chronic migraine are pharmacological and are aimed at both acute relief (e.g., nonsteroidal anti-inflammatory drugs, triptans, and ergots) and prophylaxis (e.g., propranolol, valproic acid, and topiramate). For patients with medically refractory migraine, acute relief medication overuse can increase the risk of developing more severe and more frequent migraine attacks. Occipital nerve stimulation is a non-pharmacological alternative treatment for chronic migraine, which could eliminate the risk of adverse effects from acute relief medication overuse. Neurostimulation is thought to prevent pain by blocking signal transduction from small nociceptive fibers with non-painful signaling in larger adjacent fibers.

Summary

Existing data from clinical trials support the overall safety and efficacy of occipital nerve stimulation for the treatment of chronic migraine. However, few large controlled, double-blinded studies have been conducted, due to both practical and ethical concerns. Currently, occipital nerve stimulation is available as an off-label use of neurostimulation for pain prevention but is not approved by the FDA specifically for the treatment of chronic migraine.

Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, et al. The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results. Cephalalgia. 2015;35(7):563–78.CrossRefPubMedPubMedCentral

Burch R. Migraine and Tension-Type Headache: Diagnosis and Treatment. Vol. 103, Medical Clinics of North America. W.B. Saunders. 2019. p. 215–33.

Berger A, Bloudek LM, Varon SF, Oster G. Adherence with migraine prophylaxis in clinical practice. Pain Pract. 2012;12(7):541–9.CrossRefPubMed

Diener HC, Solbach K, Holle D, Gaul C. Integrated care for chronic migraine patients: Epidemiology, burden, diagnosis and treatment options. Vol. 15, Clinical Medicine, Journal of the Royal College of Physicians of London. Royal College of Physicians. 2015. p. 344–50.

• Johnstone CSH, Sundaraj R. Occipital nerve stimulation for the treatment of occipital neuralgia - Eight case studies. Neuromodulation [Internet]. 2006 Jan [cited 2021 Jan 2];9(1):41–7. Available from: https://pubmed.ncbi.nlm.nih.gov/22151592/. This is an important case study about occipital nerve stimulation for the treatment of occipital neuralgia.

Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev. 2017;97(2):553–622.CrossRefPubMedPubMedCentral

Penfield W, McNaughton F. Dural headache and innervation of the dura mater. Arch NeurPsych. 1940;44(1):43–75. https://doi.org/10.1001/archneurpsyc.1940.02280070051003.

Akerman S, Goadsby PJ. A novel translational animal model of trigeminal autonomic cephalalgias. Headache. 2015;55(1):197–203. https://doi.org/10.1111/head.12471.

Ivanusic JJ, Kwok MMK, Ahn AH, Jennings EA. 5-HT(1D) receptor immunoreactivity in the sphenopalatine ganglion: implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache. Headache. 2011;51(3):392-402. https://doi.org/10.1111/j.1526-4610.2011.01843.x.

10.

Young WB. Blocking the greater occipital nerve: Utility in headache management. Vol. 14, Current Pain and Headache Reports. Current Medicine Group LLC 1; 2010. p. 404–8.

11.

Bartsch T, Goadsby PJ. Anatomy and physiology of pain referral patterns in primary and cervicogenic headache disorders. Headache Currents. 2005;2(2):2-48. https://doi.org/10.1111/j.1743-5013.2005.20201.x.

12.

Bartsch T, Goadsby PJ. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain. 2003.

13.

Olesen J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018.

14.

Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: Updated statistics from government health surveillance studies. Headache. 2015;55(1):21–34.CrossRefPubMed

15.

May A, Schulte LH. Chronic migraine: Risk factors, mechanisms and treatment. Vol. 12, Nature Reviews Neurology. Nature Publishing Group. 2016. p. 455–64.

16.

Mathew NT, Kurman R, Perez F. Drug Induced Refractory Headache ‐ Clinical Features and Management. Headache J Head Face Pain. 1990.

17.

Sutherland HG, Albury CL, Griffiths LR. Advances in genetics of migraine. Vol. 20, Journal of Headache and Pain. BioMed Central Ltd. 2019.

18.

Honkasalo M‐L, Kaprio J, Winter T, Heikkilä K, Sillanpää M, Koskenvuo M. Migraine and Concomitant Symptoms Among 8167 Adult Twin Pairs. Headache J Head Face Pain. 1995.

19.

Polderman TJC, Benyamin B, De Leeuw CA, Sullivan PF, Van Bochoven A, Visscher PM, et al. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet. 2015.

20.

Mulder EJ, Van Baal C, Gaist D, Kallela M, Kaprio J, Svensson DA, et al. Genetic and Environmental Influences on Migraine: A Twin Study Across Six Countries. Twin Res. 2003.

21.

Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain. 2002;125(7):1496–509.CrossRefPubMed

22.

Thompson SWN, Woolf CJ, Sivilotti LG. Small-caliber afferent inputs produce a heterosynaptic facilitation of the synaptic responses evoked by primary afferent A-fibers in the neonatal rat spinal cord in vitro. J Neurophysiol. 1993.

23.

Dodick DW. Migraine. Vol. 391, The Lancet. Lancet Publishing Group. 2018. p. 1315–30.

24.

Saracco MG, Valfrè W, Cavallini M, Aguggia M. Greater occipital nerve block in chronic migraine. Neurol Sci. 2010.

25.

Anthony M. Headache and the greater occipital nerve. Clin Neurol Neurosurg. 1992.

26.

Busch V, Jakob W, Juergens T, Schulte-Mattler W, Kaube H, May A. Functional connectivity between trigeminal and occipital nerves revealed by occipital nerve blockade and nociceptive blink reflexes. Cephalalgia. 2006;26(1):50–5.CrossRefPubMed

27.

Melzack R, Wall PD. Pain mechanisms: A new theory. Science. 1965;150:971–9.CrossRefPubMed

28.

Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31(3):271–85.CrossRefPubMedPubMedCentral

29.

• Schwedt TJ. Occipital nerve stimulation for chronic migraine-interpreting the ONSTIM feasibility trial [Internet]. Vol. 31, Cephalalgia. SAGE Publications UK; 2011 [cited 2021 Jan 11]. p. 262–3. Available from: https://doi.org/10.1177/0333102410383591. This is an important trial about occipital nerve stimulation for chronic migraine.

30.

•• Treatment for Migraines With an Implantable Device - Full Text View - ClinicalTrials.gov [Internet]. [cited 2021 Jan 11]. Available from: https://clinicaltrials.gov/ct2/show/study/NCT00286078?term=occipital+nerve&cond=migraine&draw=1&rank=18. This is an important review of clinical trials that discuses treatment for migraines with an implantable device.

31.

•• Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE - Full Text View - ClinicalTrials.gov [Internet]. [cited 2021 Jan 11]. Available from: https://clinicaltrials.gov/ct2/show/study/NCT01775735?term=occipital+nerve&cond=migraine&draw=1&rank=2. This is an important review of clinical trials that discusses Occipital Nerve Stimulation (ONS) for migraine.

32.

Study of Occipital Nerve Stimulation for Drug Refractory Migraine - Study Results - ClinicalTrials.gov [Internet]. [cited 2021 Jan 11]. Available from: https://clinicaltrials.gov/ct2/show/results/NCT00747812?term=occipital+nerve&cond=migraine&draw=1&rank=15.

33.

Serra G, Marchioretto F. Occipital nerve stimulation for chronic migraine: A randomized trial. Pain Physician. 2012;15(3):245–53.CrossRefPubMed

34.

•• An Italian Randomized Open-label Study of Occipital Nerve Stimulation in the Treatment of Chronic Migraine Headache - Full Text View - ClinicalTrials.gov [Internet]. [cited 2021 Jan 20]. Available from: https://clinicaltrials.gov/ct2/show/NCT00407992?term=occipital+nerve&cond=migraine&draw=1&rank=6. This is an important review of clinical trials that discusses an Italian randomized open-label study of Occipital Nerve Stimulation in the treatment of chronic migraine headache.

35.

McGreevy K, Hameed H, Erdek M. Updated perspectives on occipital nerve stimulator lead migration: case report and literature review. Clin J Pain. 2012;28(9):814–8.CrossRefPubMed

36.

Sharan A, Huh B, Narouze S, Trentman T, Mogilner A, Vaisman J, et al. Analysis of Adverse Events in the Management of Chronic Migraine by Peripheral Nerve Stimulation. Neuromodulation Technol Neural Interface [Internet]. 2015 Jun 1 [cited 2021 Jan 22];18(4):305–12. Available from: https://doi.org/10.1111/ner.12243.

37.

Rodrigo D, Acín P, Bermejo P. Occipital nerve stimulation for refractory chronic migraine: Results of a long-term prospective study. Pain Physician. 2017;20(1):E151–9.CrossRefPubMed

38.

Trentman TL, Rosenfeld DM, Vargas BB, Schwedt TJ, Zimmerman RS, Dodick DW. Greater Occipital Nerve Stimulation via the Bion® Microstimulator: Implantation Technique and Stimulation Parameters. Pain Physician. 2009;12:621–8.CrossRefPubMed

39.

Chakravarthy K, Fishman MA, Zuidema X, Hunter CW, Levy R. Mechanism of Action in Burst Spinal Cord Stimulation: Review and Recent Advances. Pain Med (United States). 2019;20:S13-22.CrossRef

40.

Garcia-Ortega R, Edwards T, Moir L, Aziz TZ, Green AL, FitzGerald JJ. Burst Occipital Nerve Stimulation for Chronic Migraine and Chronic Cluster Headache. Neuromodulation. 2019;22(5):638–44.CrossRefPubMed

41.

Hann S, Sharan A. Dual occipital and supraorbital nerve stimulation for chronic migraine: A single-center experience, review of literature, and surgical considerations. Neurosurg Focus. 2013;35(3):1–8.CrossRef

Titel: Occipital Nerve Stimulation: An Alternative Treatment of Chronic Migraine
verfasst von: Benjamin S. Maxey
John W. Pruitt
Ashley Deville
Carver Montgomery
Alan D. Kaye
Ivan Urits
Publikationsdatum: 14.03.2022
Verlag: Springer US
Erschienen in: Current Pain and Headache Reports / Ausgabe 4/2022
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI: https://doi.org/10.1007/s11916-022-01026-w

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Occipital Nerve Stimulation: An Alternative Treatment of Chronic Migraine